Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Henry Barnard

Orthopaedic Surgery of the Spine Albany, GA Medical Doctor

NPI 1588665277 CMS profile 298753

2311 Lake Park Dr, Albany, GA 31707

Open in the dashboard

General payments

$6,334

89 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Henry Barnard of Albany, GA is reported in the CMS Open Payments database as having received $6,334 across 89 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 38th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $278 8
2024 General $1,636 9
2023 General $1,485 17
2022 General $298 7
2021 General $485 12
2020 General $346 7
2019 General $1,806 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Henry Barnard
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Henry Barnard were reported at $278. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Henry Barnard Orthopaedic Surgery of the Spine median Middle half National median
2019 $1,806 $2,106 $337–$18,608 $163
2020 $346 $1,213 $156–$15,082 $114
2021 $485 $1,834 $271–$15,617 $132
2022 $298 $2,015 $320–$17,036 $149
2023 $1,485 $1,925 $336–$14,599 $160
2024 $1,636 $2,110 $341–$12,483 $164
2025 $278 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $4,660 37 payments
  2. Djo, LLC $449 15 payments
  3. Boston Scientific Corporation $269 5 payments
  4. Orthofix Medical, Inc. $226 4 payments
  5. Providence Medical Technology, Inc. $105 2 payments
  6. Vertos Medical, Inc. $73 1 payment
  7. Globus Medical, Inc. $72 1 payment
  8. RTI Surgical, Inc. $60 3 payments
  9. Stimwave Technologies Incorporated $52 2 payments
  10. Sanara MedTech Inc. $45 2 payments
  11. Other $324 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,296 79 payments
  2. Travel and Lodging $3,038 10 payments
Products named General payments · program years 2019–2025
  1. EVEREST SPINAL SYSTEM $2,675 17 payments
  2. XIA $878 11 payments
  3. AIRO $837 1 payment
  4. SERRATO $641 5 payments
  5. TRITANIUM $229 3 payments
  6. ASCENT;ASCENT LE;FIREBIRD SFS;ICON SFS;SFS $203 3 payments
  7. CMF Osteogenesis Stimulators $201 6 payments
  8. CMF Osteogenesis Stimulators $151 4 payments
  9. AVIATOR $147 1 payment
  10. RADIUS $139 1 payment
  11. Other $1,607 49 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

2,336

Median for Orthopedic Surgery: 203

Drug cost

$17,930

Median for Orthopedic Surgery: $1,433

Branded share of claims

6.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 542 $5,108
Diclofenac Sodium Generic 304 $3,391
Celecoxib Generic 216 $2,792
Methylprednisolone Generic 331 $1,933
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 107 $951
Duloxetine Hcl Generic 44 $919
Pregabalin Generic 69 $857
Meloxicam Generic 366 $751
Tramadol Hcl Generic 154 $380
Acetaminophen-Codeine Acetaminophen With Codeine Brand 43 $348

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 76 billing codes

Paid by Medicare

$144,503

Of which drugs: $3,099

Medicare patients

436

Average age 75

Services billed

4,807

245 women, 191 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Diabetes 32%
Chronic kidney disease 29%
Ischemic heart disease 26%
Depression 25%
COPD 20%
Osteoporosis 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 205 2,573 $1,883

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Wegovy
  • Novo Nordisk Inc $15
$15 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

89 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record